Nanomerics Completes Dosing in OC134 SUNLIGHT Trial
09 Jan 2025 //
ACCESSWIRE
Quotient & Nanomerics Dose First Volunteers OC134 SUNLIGHT Trial
01 Jan 2025 //
PRESS RELEASE
Quotient, Nanomerics Launch OC134 SUNLIGHT Study
11 Dec 2024 //
PRESS RELEASE
MHRA Grants Nanomerics Clinical Trial Authorization for OC134
18 Nov 2024 //
ACCESSWIRE
Nanomerics Wins the United Kingdom King’s Award for Enterprise Innovation 2024
06 May 2024 //
ACCESSWIRE
Nanomerics Announces Ocular MET Patent Granted in Canada
13 Apr 2023 //
ACCESSWIRE
Nanomerics Awarded an MHRA Innovation Passport for OC134
31 Aug 2022 //
ACCESSWIRE